Elevation Oncology, Inc.
SEC CIK 1783032 · ELEV · last insider filing 2025-07-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Clackson Timothy P | Director | filed 2021 - 2025 |
| Elms Steve | Director | filed 2021 - 2025 |
| Carruthers R Michael | Director | filed 2021 - 2025 |
| Cherrington Julie M | Director | filed 2024 - 2025 |
| Sandler Alan B. | Director | filed 2024 - 2025 |
| Mootz Darcy | Director | filed 2024 - 2025 |
| Ferra Joseph J Jr | Director · INTERIM CEO & CFO | filed 2021 - 2025 |
| Hu Lori | Director | filed 2021 - 2023 |
| Walsh Colin | Director | filed 2021 - 2023 |
| Leland Shawn | Director · President, CEO | filed 2021 - 2022 |
| Gaster Richard | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Furlong Tammy | CHIEF FINANCIAL OFFICER | filed 2023 - 2025 |
| Dornan David | Chief Scientific Officer | filed 2022 - 2025 |
| Jansen Valerie Malyvanh | Chief Medical Officer | filed 2021 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.